Achiko and TrustScan, a Singapore based technology start-up, have announced a partnership that will make TrustScan’s patent-pending smartphone based COVID-19 test passport technology available for the Achiko Platform. In the partnership, Achiko will take the role of a logistics or execution partner for TrustScan, providing its users with a digital certificate on their smartphone whenever they take a
COVID-19 test. By making COVID-19 test results valuable, people will be able to show a current and counterfeit protected version of their individual test results to hotels, workplaces or restaurants.
In the future options, contact tracing options for users could be provided too, given concerns about data privacy will be solved. Beyond COVID-19, the technology provides for an infrastructure which can then be used for ticketing or healthcare, among other applications.
Though the market potential could be significant, we have not included the revenue and earnings impacts in our forecasts yet, (i) for being on the conservative side with our forecasts, and (ii) for the shares of Achiko trading already below the intrinsic value of Achiko’s existing asset portfolio, in our view. However, should the ambitious management expectations be confirmed over the coming months, we believe that further adjustments to our estimates become necessary. We reiterate our discounted cash flow entity model (primary valuation method) driven price target of USD 1.20 and our Buy rating for the shares of Achiko Ltd.
Founded in 2010, Sphene Capital is a German based pure-play research house offering state-of-the-art research and evaluation services to European small- and mid-caps by avoiding typical conflict of interests of traditional investment banks.
As a general rule, analysts of Sphene Capital strive to understand companies better than any other analyst or investor before publishing their initiation reports. Therefore, the comprehensive initiation research reports comprise of 50-80 pages, including an extensive analysis of the value chain of the IPO candidate, its unique selling proposition, an elaborate analysis of suppliers and clients, a thorough SWOT analysis, a commercial due diligence (i. e. market and competitive analysis), an integrated financial forecast model and a profound company valuation (both DCF methodology and peer group multiples). Before publication, each of Sphene Capital’s research report will be double-checked by a fellow research colleague (“Four-eyes-principle”), ensuring highest quality and avoiding careless mistakes.
After initiation of research coverage, Sphene Capital publishes regular updates of 12-30 pages following relevant news flow from the issuer or major peers, f. ex. after acquisitions or after publication of quarterly results.
Due to Sphene Capital’s extensive experience in equity and bond research, the team has established longstanding contacts to all relevant market players, i. e. institutional investors, family offices and high net-worth individuals as well as journalists. To each of these groups, Sphene Capital’s research analysts have regular contacts during analyst and management roadshows or via daily phone calls. Finally, analysts publish articles in selected stock markets magazines and websites in which the analysts help issuers to improve their popularity on the German capital markets.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.